DIN/PIN Detail - 02314940

920000   MISCELLANEOUS THERAPEUTIC AGENTS

FOSAVANCE 70 MG * 5,600 UNIT ORAL TABLET

(ALENDRONATE SODIUM/ VITAMIN D3)

Manufacturer:
MERCK CANADA INC.
ECDET Review Status/Past Decision(s):
N/A
CDR Status/Past Decision(s):

 2014/02/01 - Change to Regular Benefit


 2012/12/01 - Special Authorization Criteria Change


 2011/07/01 - Special Authorization Criteria Change


 2009/10/01 - Special Authorization


 CDR - List in a similar manner to other drugs in class


To return to the printable Drug Benefit List and related publications, click here.

Last Updated: null

NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.

Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.